Abbott Laboratories · NYSE:ABT

Abbott Laboratories — Merger or Acquisition (May 2014)

4 slides from Abbott Laboratories's merger presentation, May 2014

  1. Slide 1: Abbott's Acquisition of CFR Pharmaceuticals

    Slide 1: Abbott's Acquisition of CFR Pharmaceuticals

    Abbott’s Acquisition of CFR Pharmaceuticals

  2. Slide 2: CFR Pharmaceuticals Overview

    Slide 2: CFR Pharmaceuticals Overview

    CFR Pharmaceuticals Overview Overview Branded generics pharmaceutical company with leading presence in Latin America and operations in 15 countries in the region Headquarters Santiago, Chile Founded 1922 Major Market Women’s Health, Central Nervous Segments System, Cardiovascular and Respiratory Dis

  3. Slide 3: CFR Pharmaceuticals Overview: Geographic and Therapeutic Diversity

    Slide 3: CFR Pharmaceuticals Overview: Geographic and Therapeutic Diversity

    CFR Pharmaceuticals Overview Geographic and Therapeutic Diversity Product Sales Product Sales by Geography by Therapeutic Area Complex Health and Wellness Therapeutics For institutional use Chile 11.2% 21% Colombia 21.5% 30% $768 Other 4.5% $768 Argentina 12% million million in 2013 in 2013 21% 62.9

  4. Slide 4: Leading Latin America Presence

    Slide 4: Leading Latin America Presence

    Leading Latin America Presence Comprehensive • More than 1,000 products; Product Portfolio strong pipeline • Well aligned with Abbott’s therapeutic areas: Women’s Health, Central Nervous System and Cardiovascular and Respiratory Disease • Efficient development and regulatory organizations that can r

Source: Internet Archive copy of abbott.com

More decks from Abbott Laboratories

All 34 Abbott Laboratories decks